Načítá se...
Prevention of Stroke by Antithrombotic Therapy in Patients with Atrial Fibrillation
Atrial Fibrillation (AF) is the most common clinically significant sustained cardiac arrhythmia, a major risk factor for strokes whether it is symptomatic or silent. The older CHADS(2) score and the newer CHADS(2)-VASc are well validated to determine stroke risk and guide initiation of antithromboti...
Uloženo v:
| Vydáno v: | J Atr Fibrillation |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Cardiofront, Inc
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5153105/ https://ncbi.nlm.nih.gov/pubmed/28496810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.732 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|